AMD invests $20M in AI-powered drug discovery company Absci
Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop new hardware and software optimized for the healthcare sector. The effort will place particular emphasis on developing technologies that can advance drug discovery.
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company entered into a strategic collaboration with Advanced Micro Devices Inc (NASDAQ:AMD) to enhance its AI drug discovery capabilities.
Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, ...
With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.
This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.
Novo Nordisk expanded a deal with Valo Health to discover and develop treatments for obesity, type 2 diabetes and ...
Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...
Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...
Absci Corporation (ABSI), a Washington-based biotechnology company, Wednesday has announced a strategic collaboration with AMD to ...
FBI operation leaders said the tunnel's discovery via a multi-agency operation would disrupt the drug trade between the US ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback